Patent Assignment
Reel/Frame 025671/0561
Certificate of Appointment
Recorded: 2011-01-20
Pages: 5
Assignor
IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
Executed: 2006-07-18
Assignee
HOCHEGGER, HERBERT, DR.
BRUCKNERSTRASSE 4/5, WIEN, 1040, AUSTRIA
Covered Property
(1)
Immunogenic, Monoclonal Antibody
Application:
12/749,456 →
Publication:
US 2010/0310551
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 4, 2010
From: LOIBNER, HANS; WAXENECKER, GUNTER; HIMMLER, GOTTFRIED; ECKERT, HELMUT
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 024489/0670 →
Change of Name
Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
Reel/Frame 025672/0254 →
Assignment of Assignor's Interest
Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: GREENOVATION BIOTECH GMBH; VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
Reel/Frame 025672/0318 →
Assignment of Assignor's Interest
Jan 20, 2011
From: VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
To: MERIDIAN BIOPHARMACEUTICALS GMBH
Reel/Frame 025672/0331 →